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Abstract
 
We have generated mice with a deficiency in T1/ST2 expression to clarify the roles of T1/ST2
in T helper cell type 2 (Th2) responses. Using immunological challenges normally character-
ized by a Th2-like response, we have compared the responses of T1/ST2-deficient mice with
those generated by wild-type mice. Using a primary pulmonary granuloma model, induced
with 
 
Schistosoma mansoni
 
 eggs, we demonstrate that granuloma formation, characterized by
eosinophil infiltration, is abrogated in T1/ST2-deficient mice. Furthermore, we clearly dem-
onstrate that in the absence of T1/ST2 expression, the levels of Th2 cytokine production are
severely impaired after immunization. Thus, in a secondary pulmonary granuloma model,
draining lymph node cells from the T1/ST2-deficient animals produced significantly reduced
levels of IL-4 and IL-5, despite developing granulomas of a magnitude similar to those of wild-
type mice and comparable antigen-specific immunoglobulin isotype production. These data
clearly demonstrate that T1/ST2 expression plays a role in the development of Th2-like cyto-
kine responses and indicate that effector functions are inhibited in its absence.
Key words: T1/ST2 • T helper type 2 cells • immunoglobulin • pulmonary inﬂammation • 
mast cells
 
Introduction
 
Although Th2 cells (characterized by their expression of
cytokines such as IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13)
mediate beneficial responses to infection with parasitic gas-
trointestinal nematodes (1, 2), they have been shown to be
detrimental in the development of asthma and allergy (3,
4). These effects are due to Th2 cells initiating responses
including increased production of IgE and eosinophilia (5,
6). Recently, the IL-1 receptor–related molecule T1/ST2
has been reported to distinguish a subset of CD4
 
1
 
 T helper
cells of the Th2 subtype, characterized by their elevated ex-
pression of the cytokines IL-4, IL-5, and IL-13 (7–9).
However, the T1/ST2 receptor is also expressed on mast
 
cells (10, 11) and was described originally as a serum-
induced gene in fibroblasts (12–15). Alternative transcrip-
tional regulation results in the production of soluble and
transmembrane forms of the T1/ST2 protein due to the
use of different polyadenylation signals (16, 17). The
mRNA encoding the soluble form is induced upon stimu-
lation of fibroblasts (12–15), whereas mRNA encoding the
membrane-anchored form is expressed in the hematopoie-
tic tissues and lung (16, 18). The T1/ST2 gene is tightly
linked to the genes encoding the type I and type II IL-1 re-
ceptor on mouse chromosome 1 (19) and human chromo-
some 2 (20, 21). The biological function of the T1/ST2
receptor remains unclear, but its homology with Toll re-
ceptors and other IL-1 family members (22) suggests that it
may play a central role in innate and adaptive immune re-
sponses.
Indeed, recent studies have suggested that administration
of a neutralizing antibody against T1/ST2 or a T1/ST2–Ig
fusion protein is capable of partially inhibiting Th2 cell dif-
ferentiation and the development of Th2 effector functions
in vivo, including allergic airway inflammation (7, 8, 23).
However, a further study using a line of T1/ST2-deficient
animals has suggested that T1/ST2 is not necessary for Th2
cell differentiation or effector function (24). Using parasitic
infection with the helminth 
 
Nippostrongylus braziliensis
 
,
these investigators failed to show differences in IL-4 pro-
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duction from polyclonally activated splenocytes or changes
in total serum IgE or IgG1 (24). Similarly, they also found
that total serum IgE and IgG1 and immune cell phenotypes
were normal in a model of airway inflammation (24). Thus,
there appears to be a contradiction between the results ob-
tained using T1/ST2 blocking reagents and those gener-
ated using T1/ST2-deficient animals.
We now demonstrate using a novel line of T1/ST2-
deficient mice that although T1/ST2 does not appear to
play an observable role in the generation of Th2 cytokines
or Igs in naive animals, its presence can significantly affect
the onset of Th2 cytokine responses to antigenic challenge.
Using a model of pulmonary granuloma formation, we
show that the onset of primary lung granuloma formation is
severely inhibited in T1/ST2-deficient mice. In addition,
Th2 cytokine production by the draining lymph nodes
during secondary granuloma development is dramatically
reduced, although after presensitization, granuloma mor-
phology is normal, as is the induction of antigen-specific Ig
isotype responses.
 
Materials and Methods
 
Targeted Disruption of the Mouse T1/ST2 Gene in Embryonic
Stem Cells.
 
The replacement vector was constructed to insert
the neomycin resistance gene between an engineered XbaI site in
exon 4 and an engineered BamHI site in exon 5 of the T1/ST2
gene, thereby deleting the majority of exons 4 and 5. The target-
ing vector consisted of 5.1 kb of the T1/ST2
 
 
 
gene, providing the
5
 
9
 
 arm of homology, and 2 kb comprising the 3
 
9
 
 arm of homol-
ogy. The arms of homology were generated by long-range PCR,
using Pfu turbo polymerase (Stratagene) to prime from a lambda
phage containing the 5
 
9
 
 end of the T1/ST2 gene (
 
l
 
ST2 includ-
ing exons 1–7). The 5
 
9
 
 arm of homology was generated using the
oligonucleotides 5
 
9
 
-AGTGCATCTAGAGATACTGATGAGGC-
ACC and 5
 
9
 
-CTTCTTTCTAGATTATTCAAGTTGGGGC-
TATTAAAAGAAGCC, and the 3
 
9
 
 arm of homology was created
using the oligonucleotides 5
 
9
 
-CCACCGGATCCTTCACAGT-
TGAAGGTAAGCTCTTGGCTTCAACAAGGG and 5
 
9
 
-GGA-
AGGAAAAAAGCGGCCGCGATCTCGCTCCACAGAGATG-
AGGAACGGCC. The targeting vector was linearized and
electroporated into E14.1 embryonic stem (ES) cells (25). Of
1,600 G418-resistant clones screened by Southern analysis using
probe A, 5 were targeted correctly. Probe A (184 bp) was gener-
ated using the PCR primers 5
 
9
 
-TACGTAACCTCCCATGTG-
CAGTCCTTGCTGCC and 5
 
9
 
-GTCACATCACAGGCATGA-
GGG. Hybridization with a probe to the neomycin sequence
confirmed the predicted size of the targeted fragment and that
only a single integration had occurred. Two of the targeted ES
cell clones were microinjected into 3.5-d C57BL/6 blastocysts to
generate chimaeras. These mice were mated with C57BL/6 mice
and transmitted the ES cell genotype through the germline. Mice
homozygous for the disrupted T1/ST2 gene were obtained by
interbreeding the heterozygotes. The T1/ST2 gene–targeted and
wild-type animals used in the experiments reported below were
maintained on a 129 
 
3
 
 C57BL/6 (F
 
2
 
) background in a specific
pathogen–free environment.
 
In Vitro Th Cell Differentiation Assays.
 
Splenocytes or mesen-
teric lymph node cells were cultured on anti-CD3
 
e
 
 antibody–
coated plates (1 
 
m
 
g/ml
 
 
 
of clone 2C11; Becton Dickinson) in the
presence of exogenous cytokines or anticytokine antibody as indi-
 
cated. IL-2 (10 ng/ml; R & D Systems, Inc.) was added to all cul-
tures. Th2 cell differentiation was promoted in the presence of
100 ng/ml
 
 
 
of IL-4 (R & D Systems, Inc.) and anti–IFN-
 
g
 
 anti-
body (10 
 
m
 
g/ml
 
 
 
of clone XMG1.2; Becton Dickinson), and Th1
differentiation was promoted by anti–IL-4 antibody at 10 
 
m
 
g/ml
(clone 11B11; DNAX Research Institute) and IL-12 (1 ng/ml;
Genzyme Corp.). Cells were cultured for 5 d, washed, and resus-
pended at 10
 
6
 
 cells per milliliter for 24 h in the presence of plate-
bound anti-CD3. Supernatants were analyzed by cytokine ELISA.
 
Pulmonary Granuloma Formation.
 
Primary synchronous pul-
monary granulomas were induced by intravenous injection of
mice with 
 
Schistosoma mansoni
 
 eggs (26). 
 
S
 
.
 
 mansoni
 
 eggs were iso-
lated from the livers of infected mice as described (27). 11 d after
intravenous egg injection, mice were killed, and the lungs were
inflated with formal saline and processed for histology. The hori-
zontal and perpendicular diameters of the granulomas surrounding
individual eggs were measured with an ocular micrometer. All
sections were measured by the same individual using a blind pro-
tocol. The volume of the egg granuloma was calculated assuming
a spherical shape. Greater than 100 individual granulomas were
analyzed per group.
Secondary synchronous pulmonary granulomas were induced
as follows. Mice were sensitized to schistosome eggs by intraperi-
toneal injection of 5,000 eggs. 11 d later, sensitized mice, four to
five mice per group, were injected intravenously with 5,000 eggs
to induce synchronous pulmonary granulomas. 11 d after intrave-
nous egg injection, mice were killed, and the draining mediastinal
lymph nodes were removed. The lungs were processed for histol-
ogy as described above. Cells were prepared from pooled medias-
tinal lymph nodes from each group and processed for cell culture
as described (27). 3 
 
3
 
 10
 
6
 
 cells per milliliter were cultured and re-
stimulated with 10 
 
m
 
g/ml of soluble egg antigen or anti-CD3
mAb for 72 h. Cytokines were assayed in supernatants using
ELISA. Serum samples were assayed for schistosome antigen–spe-
cific Ig isotypes as detailed below. Statistical analysis was per-
formed using ANOVA (analysis of variance) and a Dunnet test.
 
P 
 
, 
 
0.05 was considered significant.
 
Total Serum Antibody ELISA.
 
Serum Igs were assayed using
sandwich ELISA. 96-well plates were coated with monoclonal
anti-Ig isotype capture antibodies, and bound Ig of diluted serum
samples was detected using biotinylated monoclonal anti-Ig iso-
type detection antibodies (Becton Dickinson). Concentrations
were calculated using purified Ig isotypes as standards (Becton
Dickinson).
 
Antigen-specific Antibody ELISA.
 
With the exception of anti-
gen-specific IgE, schistosome egg antigen–specific isotype re-
sponses were measured using ELISA by coating 96-well plates
with soluble egg antigen at 5 
 
m
 
g/ml; bound Ig of diluted serum
samples was detected using biotinylated monoclonal anti-Ig iso-
type detection antibodies (Becton Dickinson). Schistosome egg
antigen specific serum IgE was determined using a two-step sand-
wich ELISA based on the method of van Halteren et al. (28).
ELISA plates were coated at 2 
 
m
 
g/ml with an anti–mouse IgE
mAb (clone R35-72; PharMingen). Serum samples were added
and the plates incubated for 1 h at room temperature. After wash-
ing, digoxigenin (DIG)-coupled soluble egg antigen, prepared
from a kit containing DIG-3-
 
O
 
-methylcarbonyl-
 
e
 
-amonocaproic
acid 
 
N
 
-hydroxy-succinimide ester (Boehringer Mannheim) was
added and incubated for 1 h at room temperature. After washing,
anti-DIG-Fab fragments coupled to peroxidase (Boehringer Mann-
heim) were used to detect bound antibody.
 
Cytokine ELISA.
 
Cytokine ELISA also used the sandwich
format with capture and detection antibodies purchased from 
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Becton Dickinson. ELISAs were performed according to Becton
Dickinson ELISA protocol.
 
Mast Cell Preparation.
 
Bone marrow was aseptically flushed
from femora and tibias of 8-wk-old mice. The cell suspension
was cultured at 4 
 
3
 
 10
 
5
 
 cells per milliliter in the presence of 5
ng/ml
 
 
 
of IL-3 and 10% WEHI-3B conditioned supernatant for
3–4 wk, with media changes every 7 d. The resultant cell popula-
tions were 95% c-kit
 
1
 
 and Gr-1
 
1
 
 when analyzed by flow cytom-
etry (PharMingen). Mast cells were stained using the biotinylated
anti-T1/ST2 mAb DJ8 (11).
 
Eosinophil Peroxidase Assay for Lung Tissue Eosinophilia.
 
Tissue
eosinophilia was determined using the eosinophil peroxidase assay
(29). The numbers of eosinophils (expressed as 10
 
6
 
 per gram of
tissue) were interpolated from a standard curve prepared from
eosinophils purified from the blood of 
 
N. braziliensis
 
–infected
mice.
 
Results and Discussion
 
Generation of T1/ST2-deficient Mice.
 
The targeting vec-
tor was designed to delete the majority of exons 4 and 5
and replace them with the neomycin resistance cassette af-
ter homologous recombination (Fig. 1 A). These exons
constitute part of the extracellular portion of the T1/ST2
receptor and are common to both the membrane-bound
and soluble forms of the protein (15). Genotyping of wild-
type (T1/ST2
 
1
 
/
 
1
 
), heterozygous (T1/ST2
 
1
 
/
 
2
 
), and ho-
mozygous null (T1/ST2
 
2
 
/
 
2
 
) mice is shown in Fig. 1 B.
The T1/ST2
 
2
 
/
 
2
 
 mice were healthy and displayed no overt
phenotypic abnormalities. Analysis of the T1/ST2
 
2
 
/
 
2
 
 mice
failed to detect T1/ST2 RNA transcripts from activated
lymphocytes using reverse transcriptase–PCR assays (data
not shown), and flow cytometry also failed to identify T1/
ST2 protein on the surfaces of cultured mast cells (Fig. 1 C)
 
or CD4
 
1
 
 T cells from spleen or lymph node (data not
shown). Naive animals were examined to determine the ef-
fects of T1/ST2 disruption on the immune system. Fur-
thermore, we also assessed the immune responses of the
T1/ST2
 
2
 
/
 
2
 
 animals to immunological challenges that nor-
mally provoke a Th2 phenotype.
 
Naive Immune Cell Populations, Cytokine Levels, Th1 and
Th2 Cell Development, and Total Ig Isotype Production Are
Normal in T1/ST2
 
2
 
/
 
2
 
 Mice.
 
Flow cytometric analysis of
cells derived from naive T1/ST2-deficient and wild-type
animals failed to show differences in the cell surface expres-
sion of CD4, CD8, TCR, CD3, CD5, CD25, CD45, and
Figure 1. Inactivation of the T1/ST2 gene by
homologous recombination. (A) The structure of
the T1/ST2 locus, the targeting vector, and the
predicted homologous recombination event are
shown. Targeted disruption results in the deletion
of the majority of exons 4 and 5. NeoR, neomycin
resistance cassette; TK, thymidine kinase cassette;
B, BamHI; X, XbaI; N, NotI. Intron–exon bound-
aries are inferred from the rat gene sequence (16).
(B) Southern blot of F2 tail genomic DNA. The in-
dicated probe detects a 5.7-kb BamHI fragment in
the wild-type T1/ST2 gene and a 2.7-kb fragment
as a result of the correct homologous recombina-
tion event. (C) Analysis of T1/ST2 expression by
mast cells. Mast cells were cultured from bone mar-
row in the presence of IL-3 and stem cell factor.
Biotinylated anti-T1/ST2 (DJ8) was used to stain
for T1/ST2 expression.
Figure 2. Analysis of naive T helper cell differentiation. Cytokine pro-
duction after in vitro Th cell differentiation. Mesenteric lymph node cells
or splenocytes from three wild-type or three IL-132/2 mice were stimu-
lated under Th1 or Th2 culture conditions for 5 d, washed, and restimu-
lated on anti-CD3 antibody–coated plates for 24 h. Supernatants were an-
alyzed by ELISA. Data are representative of three repeat experiments. 
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Gr-1 on thymocytes; CD4, CD8, TCR, CD3, CD5,
CD14, CD23, CD45, Gr-1, CD11b, and TER119 on me-
senteric lymph node cells or splenocytes; CD3, CD5,
CD14, CD23, CD24, CD43, CD45, Gr-1, CD11b,
TER119, BP1, and c-kit on bone marrow; and CD5,
CD45, CD11b, c-kit, and Gr-1 on peritoneal lavage (data
not shown).
Stimulation of mesenteric lymph node cells or spleno-
cytes from naive animals with polyclonal activators of T
 
cells demonstrated that IL-4, IL-5, IL-10, and IFN-
 
g
 
 pro-
duction from these cellular pools was not altered by the ab-
sence of the T1/ST2 receptor (data not shown). Further-
more, when lymph node cells or splenocytes were cultured
in vitro under conditions that promote the differentiation
of Th1 or Th2 cells, no significant differences were ob-
served in these lineages from cultures derived from T1/
ST2-deficient or wild-type animals (Fig. 2). Polyclonal ac-
tivation of cultured mast cell populations from wild-type
and T1/ST2-deficient animals also failed to identify a dif-
ference in cytokine production (data not shown). In addi-
tion, total serum Ig isotype responses from naive T1/ST2
 
2
 
/
 
2
 
mice were also comparable to those detected in wild-type
animals (Fig. 3). Thus, the absence of T1/ST2 expression
does not appear to have compromised the basal immune
functions of the T1/ST2
 
2
 
/
 
2
 
 mice. These results imply that
the cell surface expression of T1/ST2 is not necessary for
immune competence in naive animals that are not under-
going immune challenge. Our in vitro T cell differentiation
data also demonstrate that expression of T1/ST2 is not crit-
ical for the development of naive T cells toward a Th2
Figure 3. Total serum Ig isotype production from naive wild-type (h)
and T1/ST22/2 (d) mice. Represented data points indicate individual
animals. 
Figure 4. Analysis of primary pulmonary inflammatory response. (A)
Determination of granuloma volumes in immunized mice. Cohorts of
four to five mice were injected intravenously with 5,000 schistosome eggs
to induce synchronous pulmonary granuloma. Mice were killed 11 d
later. Lung sections were stained with hematoxylin and eosin, and at least
100 individual granulomas were measured per group. Data are presented
as means less egg volumes plus SD. (B) Morphological analysis of granu-
loma formation in wild-type (WT) and T1/ST22/2 (KO) mice. Lung
sections were stained with hematoxylin and eosin. Magnification, 63.
Data are representative of two repeat experiments.
Figure 5. Analysis of presensitized pulmonary inflammatory response.
Cohorts of four to five mice were sensitized by intraperitoneal injection
of 5,000 S. mansoni eggs. After 11 d, these mice were injected intrave-
nously with 5,000 eggs to induce synchronous pulmonary granuloma.
Mice were killed 11 d later. (A) Cytokine responses to pulmonary chal-
lenge. Cytokine responses from activated lymph node cells. Draining me-
diastinal lymph node cells were stimulated with soluble egg antigen or
anti-CD3 antibody, and supernatants were assayed for cytokines by
ELISA. Data are presented as means plus SD. Open bars, wild-types; filled
bars, ST22/2. (B) Determination of granuloma volumes in sensitized
mice. Lung sections were stained with hematoxylin and eosin, and at least
100 individual granulomas were measured per group. Data are presented
as means less egg volumes plus SD and are representative of two repeat
experiments. WT, wild-type; KO, knockout. 
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phenotype. However, to address whether the T1/ST2
molecule mediates demonstrable effects during Th2 im-
mune responses, we challenged the T1/ST2-deficient mice
with antigens known to induce Th2 responses.
 
Induction of Primary Synchronous Pulmonary Granuloma
Formation using S. mansoni Eggs Is Severely Impaired in T1/
ST2-deficient Animals.
 
To determine the in vivo contri-
bution of T1/ST2 in a Th2 cytokine-mediated inflamma-
tory response, we employed a model system in which syn-
chronous pulmonary granuloma formation is induced
around 
 
S
 
.
 
 mansoni
 
 eggs (30). In this model, a cellular gran-
ulomatous response develops around parasite eggs that
lodge in the lungs after their intravenous injection into
mice. This inflammatory response is characterized by the
high-level expression of Th2 cytokines (31) and the infil-
tration of eosinophils (30). This model has proven ex-
tremely valuable in defining the respective effector func-
tions of cytokines involved in this Th2 response (30) and
has the advantage of generating a quantifiable inflamma-
tory cell infiltrate even during the primary response to an-
tigen.
After intravenous injection of naive wild-type mice
with schistosome eggs, granuloma formation was detected
as expected (Fig. 4 A) and consisted of eosinophil infiltra-
tion around the immobilized eggs (Fig. 4 B). In sharp con-
trast, naive T1/ST2-deficient mice failed to develop sig-
nificant pulmonary granuloma formation in response to
intravenous administration of schistosome eggs (Fig. 4 A),
and eosinophilic infiltration was not detected (Fig. 4 B).
Quantification of eosinophil numbers in the lungs using
the eosinophil peroxidase assay clearly demonstrated a 10-
fold reduction in this cell type in the T1/ST2-deficient
animals (wild-type 38.4 
 
6
 
 SE 5.6 versus T1/ST2
 
2
 
/
 
2
 
 3.4 
 
6
 
SE 0.7 [
 
P
 
 
 
5 
 
0.0035], defined as eosinophils 
 
3
 
10
 
6
 
 per
gram). Thus, the primary pulmonary granulomatous
model demonstrates that mice deficient in T1/ST2 expres-
 
sion have a severe impairment in their ability to generate
this stereotypical Th2-like inflammatory response.
Th2 Cytokine Production in Response to Secondary Pulmo-
nary Granuloma Formation Is Impaired in T1/ST2-deficient
Mice, but Secondary Granulomas Are Normal. We have also
assessed the effect of presensitizing T1/ST22/2 and wild-
type animals to egg antigens before the intravenous ad-
ministration of eggs. These animals were given a primary
administration of schistosome eggs intraperitoneally before
being challenged with an intravenous inoculation of schis-
tosome eggs. The lungs were then examined for the devel-
opment of granulomas, and the mediastinal lymph nodes
draining the lungs were analyzed for cytokine expression.
Significantly, the egg antigen–specific and polyclonally in-
duced cytokine responses generated from the draining me-
diastinal lymph nodes demonstrate that T1/ST22/2 mice
are significantly impaired in their ability to generate the
Th2 cytokines IL-4 and IL-5 but not IFN-g (Fig. 5 A).
However, after presensitization, both the wild-type and
T1/ST2-deficient mice generated secondary pulmonary
granulomas of comparable magnitude (Fig. 5 B) and cell
composition (data not shown). Furthermore, both wild-
type and T1/ST22/2 mice developed similar egg antigen–
specific Ig isotype responses to immunization after second-
ary priming despite the differences in cytokine expression
(Fig. 6). In contrast to the effects observed in naive T1/
ST2-deficient animals, these results demonstrate that T1/
ST2 expression is critically required for the unimpaired
development of a Th2 cytokine response. However, it is
also clear that after sensitization, T1/ST22/2 animals can
still generate a normal granuloma response despite produc-
ing significantly reduced levels of Th2 cytokines. These
data contrast with the results obtained using the primary
granuloma model and imply that the effects of ablating
T1/ST2 expression can be circumvented by alternative
pathways after priming of the immune response.
Figure 6. Antigen-specific Ig response to immunization.
Cohorts of four to five animals were immunized intraperi-
toneally with schistosome eggs, followed by secondary ad-
ministration of eggs intravenously. h, wild-type; j, T1/
ST22/2. Serum samples were assayed 11 d after the sec-
ondary antigen challenge by ELISA for Ig isotypes. Repre-
sentative data from two repeat experiments are shown.1074 T1/ST2-deficient Mice
Using T1/ST2-deficient mice, we clearly demonstrate a
significant role for this molecule in the generation of Th2
cytokine responses to antigen challenge in the lung. Partic-
ularly striking was the reduction in lung tissue eosinophilia
in T1/ST22/2 mice after primary granuloma formation. It
is noteworthy that although a reduction in Th2 cytokine
production was observed after secondary antigen chal-
lenges, only primary granuloma formation was significantly
impaired. These data suggest that although T1/ST2 plays a
key role in the early events involved in the generation of
Th2 immune reactions, its presence is not essential for the
generation of downstream effector functions and may be
bypassed by alternative mechanisms. However, it is also ap-
parent that in the absence of T1/ST2, the immune re-
sponse to lung damage is significantly delayed and might
constitute a selective disadvantage in a less protective envi-
ronment.
It is interesting that certain of our results appear to con-
tradict those of Hoshino et al. (24), who have also studied
T1/ST2-deficient mice. Although we agree that the pres-
ence of T1/ST2 is not necessary for the differentiation of
Th2 cells under in vitro culture conditions, we find anti-
gen-specific Th2 cytokine responses and effector function
are impaired in our T1/ST22/2 mice. It is noteworthy that
our results are supported by data from studies using re-
agents that inhibit T1/ST2 function (7, 8, 23). It is possible
that our use of short-term antigen challenge, route of ad-
ministration, and antigen-specific restimulation has un-
masked phenotypic differences that are obscured by the
multiple immunization protocol and polyclonal activation
used by Hoshino et al. (24). Although molecules that inter-
act with the T1/ST2 receptor have been reported (9, 32),
the cognate ligand has yet to be identified but would ap-
pear to be an important molecule in the initiation of Th2
immune responses. In conclusion, our study demonstrates
that T1/ST2 does play a functional role in the generation
of Th2 cytokine responses in vivo and that inhibiting its
function, in combination with inhibiting molecules such as
IL-4, IL-5, and IL-13, may offer a route for controlling the
development of atopy.
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